Thirteen patients (mean age 66 ± 10 years) with a primary, therapy-naïve PCa (median PSA 9.3 [range: 6.3–130 μg/L]) prior radical prostatectomy, were recruited in this exploratory prospective study. The gene discussed is KLK3; the disease is posterior cortical atrophy.